Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 31, 2012
Cytovance Biologics, Inc. and Fountain BioPharma, Inc. jointly announce the execution of a Biopharmaceutical Development and Manufacturing collaboration for FB301, a novel monoclonal antibody (mAb) being developed for the treatment of allergy as a ...
read more
Thursday, October 14, 2021
The Department of Air Force, in coordination with the Department of Health and Human Services (HHS), awarded a $30 million contract to Eurofins Genomics US to build a new production facility and expanded capacity for the manufacturing of reagents ...
read more
Wednesday, December 15, 2021
Gamma Biosciences, a global life sciences company serving the academic and advanced therapy market, announced the appointment of Dale Gordon as Chief Executive Officer (CEO) of its operating company Mirus Bio. Gordon succeeds founders Jon Wolff and ...
read more
Dalton Pharma Services has declared the signing of a drug development and manufacturing services agreement with Oryn Therapeutics, an American biotechnology firm.
read more
Dalton Pharma Services has announced the signing of a drug development and manufacturing services agreement with Oryn Therapeutics.
read more
Monday, November 26, 2018
Dalton Pharma announced a drug development and manufacturing services agreement with ExCellThera, a biotechnology company focused on delivering molecules and bioengineering solutions.
read more
Wednesday, January 28, 2015
Dalton Pharma Services today announced expanded cGMP sterile powder filling capabilities as part of its ongoing focus on sterile processing and manufacturing.
read more
Dalton Pharma Services announced that the FDA completed a PAI inspection of its Health-Canada licensed manufacturing facility in Canada, in January 2019.
read more
Danaher Corporation announced that Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion. Danaher expects to finance the acquisition using cash on hand and/or ...
read more
Danaher has entered into a definitive agreement with General Electric Company (GE) to acquire the Biopharma business of GE Life Sciences (GE Biopharma) for a cash purchase price of approximately $21.4 billion.
read more
Dante Labs, Cambridge Cancer Genomics, and Nonacus, a provider of genetic testing products for precision medicine and liquid biopsy, have signed a collaboration agreement.
read more
Out of an abundance of caution, and with a rapidly growing number of our participants not being able to travel, we’ve made the difficult decision to cancel DCAT Week 2020.
read more
DCPrime BV and apceth Biopharma GmbH announced they have entered into a strategic manufacturing agreement.
read more
Particle Sciences has broadened its Drug Enforcement Administration (DEA) registration to become an authorized manufacturer of Schedule I substances.
read more
Debiopharm and Ipsen announced renewal of their Decapeptyl® agreement, which extends their partnership through 2034 for the development, manufacturing and distribution of Decapeptyl®.
read more